Genetic polymorphisms and endothelial dysfunction in patients with essential hypertension: A cross-sectional case-control study

Netherlands Heart Journal

Volumn 13, Issue 4, 2005, Pages 126-131

  Demirel, S ^a   Akkaya, V ^a   Cine, N ^a   Oflaz, H ^a   Yekeler, E ^a   Ozturk, S ^a   Cleophas, T J ^b,d   Fici, F ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b European College of Pharmaceutical Medicine   (France)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

Endothelial dysfunction; Essential hypertension; Genetic polymorphisms

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; ECHOGRAPHY; ENDOTHELIUM; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKING; URIC ACID BLOOD LEVEL; VASODILATATION;

EID: 17444402788     PISSN: 09297456     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-7.
2. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium- dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
3. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993;21:929-33.
4. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-64.
5. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86: 228-34.
6. Forstermann U, Mugge A, Alheid U, Haverich A, Frohlich JC. Selective attenuation of endothelium-mediated vosodilation in atherosclerotic human coronary arteries. Circ Res 1988;62:185-90.
7. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88: 2510-6.
8. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27: 567-74.
9. Ramsey MW, Goodfellow J, Jones CJH, Luddington LA, Lewis MJ, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995;92:3212-9.
10. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
11. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
12. Leung WH, Lau CP, Wong CK Beneficial effect of cholesterol-lowering on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993;341:1496-500.
13. Sorensen KE, Kristensen IB, Celermajer DS. Atherosclerosis in the human brachial artery. J Am Coll Cardiol 1997;29:318-22.
14. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41.
15. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer DS, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A Report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65.
16. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993;11:1375-80.
17. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996;94:1298-303.
18. Vallance P, Collier J, Moncada S. Effect of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2: 997-1000.
19. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-52.
20. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998;32:3-8.
21. Uwabo J, Soma M, Nakayama T, Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 1998;11:125-8.
22. Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K, Esumi M. Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet 1997;51:26-30.
23. Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANEF Study). J Am Coll Cardiol 2000;35:60-6.
24. Esther CR Jr, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR, et al. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 1997;99:2375-85.
25. Lüscher TF, Boulanger CM, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension 1992;19:117-30.
26. Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994;90:2056-69.
27. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.
28. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charm A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
29. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme with essential hypertension. Biocbem Biophys Res Commun 1992;184:9-15.
30. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, et al. Angiotensin II type I receptor gene polymorphism in human essential hypertension. Hypertension 1994;24:63-9.
31. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-46.
32. Declaration of Helsinki. Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects. 52nd World Medical Assembly, Edinburgh, October, 2000.
33. Wang XL, Sim AS, Bodenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the nitric oxide synthase gene. Nature Med 1996;2:41-5.
34. Miller SA, Dykes DD, Pollesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
35. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
36. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. New Engl J Med 1995;332:706-11.
37. Nawata H, Takayanaga R, Ohnaka K, Sakai Y, Imasaki K, Yanase T, et al. Type 1 angiotensin II receptors of adrenal tumors. Steroids 1995;60:28-34.
38. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1329-445.
39. Perticone F, Ceravolo R, Maio R, Venmtura G, Zingone A, Perroti N, et al. Angiotensin-converting enzyme polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension 1998;31:900-5.
40. Rossi GP, Taddei S, Virdis A, Ghiadoni L, Albertin G, Favilla S, et al. Exclusion of the ACE D/I gene polymorphism as a determinant of endothelial dysfunction. Hypertension 2001;37:293-300.
41. Rossi GP, Taddei S, Virdis A, Cavallin M, Ghiadoni L, Favilla S, et al. The T-786C and Glu298Asp polymorphism of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 2003;41: 946-8.
42. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999;33:933-6.
43. Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 1995;91:96-102.
44. Turner ST, Boerwinkle E, Sing CF. Context-dependent associations of the ACE I/D polymorphism with blood pressure. Hypertension 1999;34:773-8.
45. Rutledge DR, Sun Y, Ross EA. Polymorphism within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 1995;13:953-5.
46. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, et al. Evidence of association of the ecNOS gene polymorphism with the plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998;245:190-3.